Alibaba's New Retail major withdrawal.

Focus on the main business.

wallstreetcnDec 17 17:29

Alibaba lost 9.3 billion and sold 100% of its shares in Intime, while Youngor Group made another successful investment.

① Alibaba will sell 100% equity of Intime Department Store to a buyer consortium composed of Youngor Group and Intime management team members. ② This year, Youngor Group has strengthened its investment in physical businesses, opening 13 new fashion experience stores offline. ③ Alibaba entered Intime in 2014 and gradually became the largest shareholder; as New Retail progressed to a decline, Alibaba ultimately let go of Intime.

cls.cnDec 17 14:40

7.4 billion! Alibaba "shakes off" the burden, Youngor Group officially takes over Silver Intime Department Store.

Analysts point out that although the Youngor Group's acquisition helps its expansion in the retail market, the department store industry is continuously shrinking.

cls.cnDec 17 13:44

U.S. stock market closing | The three major indexes had mixed results, with the Nasdaq increasing over 1% to reach a new high, while the Dow Jones fell for the eighth consecutive day; Broadcom surged over 11%, and Tesla rose over 6%, both reaching histori

The Dow Jones Industrial Average has recorded its longest losing streak since 2018; NVIDIA fell over 1%, marking its third consecutive decline; MicroStrategy, which was added to the Nasdaq 100 index, surged over 7% intraday before reversing to a loss, and Super Micro Computer, which was removed from the index, closed down over 8%. Chinese concept stocks fell over 2%.

wallstreetcnDec 17 07:06

Jiangsu Skyray Instrument has been designated as a special treat and fined 3 million yuan. In recent years, there have been 10 other instances of illegal operation in production and management. | Quick read of the announcement.

① Jiangsu Skyray Instrument was fined 3 million yuan by the Securities Regulatory Commission, and several executives including chairman Liu Zhaogui were also penalized; ② The company's stocks will be subject to other risk warnings by the Shenzhen Stock Exchange, changed to "ST Jiangsu Skyray"; ③ In recent years, the company has faced up to 10 cases of violations related to environmental protection, safety regulations, and other operational misconduct.

cls.cnDec 8 20:46

Tasly Pharmaceutical Group: Some products price reduction led to a decline in Q3 gross margin. All parties are actively promoting the trade with China Resources Sanjiu Medical & Pharmaceutical | Focus on earnings conference

① Affected by the overall low prosperity of the pharmacy industry, the company's pharmaceutical commerce sector saw a decline in revenue in the third quarter this year; the pharmaceutical industry sector's revenue grew year-on-year, but price reductions on some products led to a decrease in gross margin, and the company expects the gross margin to remain stable in the future. ② Regarding the equity trade matters between the company's major shareholder and china resources sanjiu medical & pharmaceutical, the company's general manager Cai Jinyong stated that the company and relevant parties are actively promoting various works for this transaction.

cls.cnNov 27 22:29